Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalNet MarginReturn on AssetsReturn on EquityReturn on Sales

HUTCHMED (China) (HCM) Invested Capital (2016 - 2025)

HUTCHMED (China) (HCM) has disclosed Invested Capital for 12 consecutive years, with $1.3 billion as the latest value for Q4 2025.

  • On a quarterly basis, Invested Capital rose 58.81% to $1.3 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.3 billion, a 58.81% increase, with the full-year FY2025 number at $1.3 billion, up 58.81% from a year prior.
  • Invested Capital was $1.3 billion for Q4 2025 at HUTCHMED (China), up from $795.2 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $1.3 billion in Q4 2025 to a low of $639.0 million in Q4 2022.
  • A 5-year average of $907.6 million and a median of $795.2 million in 2024 define the central range for Invested Capital.
  • Peak YoY movement for Invested Capital: skyrocketed 105.34% in 2021, then tumbled 40.08% in 2022.
  • HUTCHMED (China)'s Invested Capital stood at $1.1 billion in 2021, then crashed by 40.08% to $639.0 million in 2022, then increased by 21.22% to $774.5 million in 2023, then rose by 2.67% to $795.2 million in 2024, then skyrocketed by 58.81% to $1.3 billion in 2025.
  • Per Business Quant, the three most recent readings for HCM's Invested Capital are $1.3 billion (Q4 2025), $795.2 million (Q4 2024), and $774.5 million (Q4 2023).